Paradigm Biopharmaceuticals appoints new medical chief
Paradigm Biopharmaceuticals (ASX:PAR) appointed Dr Daniel Furtner as chief medical officer, effective Sept. 16.
Paradigm Biopharmaceuticals (ASX:PAR) appointed Dr Daniel Furtner as chief medical officer, effective Sept. 16.
Leeuwin Metals (ASX:LM1) appointed mining engineer Rubei Ma as chief development officer to advance the Marda Gold Project.
TRON (CRYPTO:TRX) has a draft quantum-security plan that could affect how some wallets recover their keys.
Falcon Metals (ASX:FAL) secured $30 million through an institutional share placement to expand multi-rig exploration programmes.
Australian defence firm Overwatch Technologies has lodged a prospectus to raise $8 million.
Australian Rare Earths (ASX:AR3) completed follow-up drilling that extended the Overland carbonatite discovery.
The UK House of Lords has voted 194–138 to require the Treasury to develop a national digital-assets strategy.
Australian first homebuyer mortgage applications dropped 20.1% in the year to August, according to credit data from Equifax.
Trek Metals (ASX:TKM) has secured an exclusive nine-month option to acquire 100% of Solution Mining.
A crypto trader has lost about US$2.1 million in Tether (CRYPTO:USDT) after scammers hijacked a business partner’s Telegram account.
GET YOUR GRAFA EDGE NOW
We'll switch on a 30-day Edge trial as a welcome gift
Got a second for a cookie? 🍪Essential cookies keep Grafa running smoothly. A few optional ones help us see what's working so we can make it better. You're in control — change your mind any time. Cookie policy · Privacy policy